Recent insider trading activity from Sattarzadeh Sherwin, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | Damora Therapeutics, Inc. | $DMRA | Sattarzadeh Sherwin | Chief Operating Officer | A | Common Stock | 190376 | $0.00 | 190,376.0000 | 1,327,212 | 9999.99% | 14.34% |
| Jan. 5, 2026 | Damora Therapeutics, Inc. | $DMRA | Sattarzadeh Sherwin | Chief Operating Officer | A | Stock Option (right to buy) | 444209 | $0.00 | 444,209.0000 | 1,327,212 | 9999.99% | 33.47% |